Reunion Neuroscience Inc. Announces Executive Changes

October 8, 2022

https://www.globenewswire.com/news-release/2022/10/07/2530577/0/en/Reunion-Neuroscience-Inc-Announces-Executive-Changes.html

TORONTO, Oct. 07, 2022 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc. (TSX:REUN, NASDAQ:REUN) (“Reunion” or the “Company”), a leader in novel psychedelic drug development committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds, today announced that Ronan Levy has resigned as Director of the Company and Paula Amy Hewitt has resigned as General Counsel & Corporate Secretary, effective October 7, 2022.

Read more at globenewswire.com

Related news for (REUN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.